CMI
MRNA icon

Clare Market Investments’s Moderna MRNA Stock Holding History

Clare Market Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,680
Closed -$978K – 158
2022
Q1 		$978K Buy
+5,680
New +$956K 0.31% 44
2021
Q1 		– Sell
-2,570
Closed -$268K – 129
2020
Q4 		$268K Buy
+2,570
New +$260K 0.11% 96

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clare Market Investments's MRNA Position: Q2 2022 in Review

Clare Market Investments sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5,680 shares — an estimated $978K sold.

Clare Market Investments first reported a position in MRNA in Q4 2020 and held it in 2 quarters. The position peaked at $978K in Q1 2022. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Clare Market Investments reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Clare Market Investments sold 5,680 Moderna shares in Q2 2022, an estimated $978K.
  • Clare Market Investments first reported a position in Moderna in Q4 2020 and held it in 2 quarters.
  • Clare Market Investments's Moderna position peaked at $978K in Q1 2022.
  • 982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Clare Market Investments's 13F filing for Q2 2022, filed 20 Feb 2025.